Dissemination of Carbapenem-Resistant Bacteria During the COVID-19 Pandemic in A Tertiary Hospital in Northern India
DOI:
https://doi.org/10.31344/ijhhs.v7i4.591Keywords:
Antibiotics, carbapenem, drug resistance, COVID-19 pandemic, intensive care unitsAbstract
Background: Carbapenemase-producing Enterobacteriaceae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Acinetobacter baumannii (CRAB) have spread rapidly in the recent years.
Objective: To look for the impact of COVID-19 pandemic on carbapenemresistance.
Methods: This retrospective, cross-sectional study was done, from March 2018 to April 2022, on an adult population of ICU patients who were found resistant to carbapenem group drugs in tracheal culture.
Results: During the COVID-19 pandemic CRE, CRPA and CRAB infections were found significantly increased.
Conclusion: Our results suggested the need to focus on CRE, CRPA and CRAB infections post-COVID-19. We explore how COVID-19 pandemic affects healthcare systems by amplifying AMR. Further studies are needed to understand the epidemiology and molecular profile of CRE, CRPA and CRAB associated infections post COVID-19. Screening is necessary when a patient has been in a hospital where carbapenem-resistant microorganisms are common, and every institution should have a specific policy in place for the management of organisms that are resistant to carbapenem that is periodically reviewed.
International Journal of Human and Health Sciences Vol. 07 No. 04 Oct’23 Page: 309-313
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Atif Khalid, Obaid Ahmad Siddiqui, Syed Hasan Amir, Farah Nasreen

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:
- Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.